PhilipRoehrsMD

Pediatric Hematology & Oncology • Charlotte, NC

Associate Professor, Pediatrics Levine Children’s Hospital Charlotte,NC

Join to view full profile

Dr. Roehrs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Roehrs' full profile

Already have an account?

Office
1000 Blythe Blvd
Charlotte, NC 28203
Phone+1 704-355-2000

Fax+1 704-355-5073

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Medical University of South CarolinaResidency, Pediatrics, 2002 - 2005
University of South Carolina School of MedicineClass of 2002

Certifications & Licensure

VA State Medical License 2021 - 2024
NC State Medical License 2010 - 2022
OH State Medical License 2005 - 2012
SC State Medical License 2004 - 2005

Clinical Trials

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL Start of enrollment: 2012 Mar 22
Recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

121 citations
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency
Andrew L. Snow, Rebecca A. Marsh, Scott M. Krummey, Philip A. Roehrs, Lisa R. Young
The Journal of Clinical Investigation. 2009-10-01
103 citations
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency
David Boutboul, Hye Sun Kuehn, Zoé Van de Wyngaert, Julie E. Niemela, Isabelle Callebaut
The Journal of Clinical Investigation. 2018-07-02
63 citations
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Carl E. Allen, Rebecca A. Marsh, Peter Dawson, Catherine M. Bollard, Shalini Shenoy
Blood. 2018-09-27

Journal Articles

Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204
Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood

Lectures

Primary HLH: Diagnosis, Management, and Treatment in the 21st Century
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Bone Marrow Transplant and Cellular TherapiesSeptember 9th, 2019